These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 7110143)

  • 1. Analysis of the antigenic relationship of various derivatives of n-acetyl-muramyl-l-ala-d-isoglutamine (MDP), using anti-MDP antibodies.
    Bahr GM; Carelli C; Audibert F; Modabber F; Chedid L
    Mol Immunol; 1982 May; 19(5):737-45. PubMed ID: 7110143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunoadjuvant effects of the synthetic muramyl-dipeptide (MDP) N-acetylmuramyl-L-alanyl-D-isoglutamine.
    Heymer B; Finger H; Wirsing CH
    Z Immunitatsforsch Immunobiol; 1978 Oct; 155(1):87-92. PubMed ID: 706536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoclonal antibodies to the synthetic adjuvant muramyl dipeptide: characterization of the specificity.
    Bahr GM; Eshhar Z; Ben-Yitzhak R; Modabber FZ; Arnon R; Sela M; Chedid L
    Mol Immunol; 1983 Jul; 20(7):745-52. PubMed ID: 6888382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Absence of antibodies to muramyl dipeptide in patients with tuberculosis or leprosy.
    Bahr GM; Modabber FZ; Rook GA; Mehrotra ML; Stanford JL; Chedid L
    Clin Exp Immunol; 1982 Jan; 47(1):53-8. PubMed ID: 6807589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of conjugates containing N-acetylmuramyl-L-alanyl-D-isoglutaminyl (MDP). Their use as hapten-carrier systems.
    Reichert CM; Carelli C; Jolivet M; Audibert F; Lefrancier P; Chedid L
    Mol Immunol; 1980 Mar; 17(3):357-63. PubMed ID: 7442679
    [No Abstract]   [Full Text] [Related]  

  • 6. Biological studies of lipophilic MDP-derivatives incorporated in liposomes.
    Jolivet M; Sache E; Audibert F
    Immunol Commun; 1981; 10(6):511-22. PubMed ID: 7319546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Further study on relationship of anti-tuberculous protection to lung granulomata produced by intravenous injections of synthetic 6-0-mycoloyl-N-acetyl-muramyl-L-alanyl-D-isoglutamine with or without specific antigens.
    Yamamoto K; Kato K; Kakinuma M; Okuyama H; Azuma I
    Immunology; 1982 Jun; 46(2):473-9. PubMed ID: 7044961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Absence of binding of MDP, a synthetic immunoadjuvant, to anti-peptidoglycan antibodies.
    Audibert F; Heymer B; Gros C; Schleifer KH; Seidl PH; Chedid L
    J Immunol; 1978 Oct; 121(4):1219-22. PubMed ID: 701793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis of conjugates between luteinizing hormone releasing hormone (LH-RH) and N-acetyl-muramyl-L-alanyl-D-isoglutamine (MDP) models of totally synthetic vaccines.
    Bernard JM; Gras-Masse H; Drobecq H; Tartar A; Lefrancier P; Hosmalin A; Carelli C; Chedid L
    Int J Pept Protein Res; 1987 Apr; 29(4):455-63. PubMed ID: 3298096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of a synthetic adjuvant (MDP) on qualitative and quantitative changes of serum globulins.
    Leclerc C; Audibert F; Chedid L
    Immunology; 1978 Dec; 35(6):963-70. PubMed ID: 738768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation for hapten help by glucan, muramyl dipeptide, and its L-ala-Glycerol-mycolate derivative.
    Leech SH; Di Luzio NR; Leclerc C
    J Leukoc Biol; 1985 Aug; 38(2):317-25. PubMed ID: 3861748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficient genetically controlled formation of antibody to a synthetic antigen [poly(LTyr, LGlu)-poly(DLAla)- -poly(LLys)] covalently bound to a synthetic adjuvant (N-acetylmuramyl-L-alanyl-D-isoglutamine).
    Mozes E; Sela M; Chedid L
    Proc Natl Acad Sci U S A; 1980 Aug; 77(8):4933-7. PubMed ID: 6776530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunostimulant activities of a lipophilic muramyl dipeptide derivative and of desmuramyl peptidolipid analogs.
    Parant MA; Audibert FM; Chedid LA; Level MR; Lefrancier PL; Choay JP; Lederer E
    Infect Immun; 1980 Mar; 27(3):826-31. PubMed ID: 7380554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antigenicity study of muroctasin.
    Yamaguchi F; Hattori H; Wagai N; Tsukada W
    Arzneimittelforschung; 1988 Jul; 38(7A):1034-7. PubMed ID: 3190797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stimulation of nonspecific host resistance to infection induced by muramyldipeptides.
    Matsumoto K; Ogawa H; Nagase O; Kusama T; Azuma I
    Microbiol Immunol; 1981; 25(10):1047-58. PubMed ID: 7031443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancement of serum antibody production in mice by oral administration of lipophilic derivatives of muramyl peptides and bacterial lipopolysaccharides with bovine serum albumin.
    Ogawa T; Kotani S; Shimauchi H
    Methods Find Exp Clin Pharmacol; 1986 Feb; 8(2):117-25. PubMed ID: 3713372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-acetyl muramyl dipeptide stimulation of bone resorption in tissue culture.
    Dewhirst FE
    Infect Immun; 1982 Jan; 35(1):133-7. PubMed ID: 7054120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis, mass spectral characterization and immunoadjuvant activity of some novel lipophilic derivatives of muramyl dipeptides.
    Jain RK; Gupta CM; Saxena RK; Saxena RP; Saxena KC; Shukla R; Anand N; Costello CE
    Chem Phys Lipids; 1986; 41(3-4):237-64. PubMed ID: 3815623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of N-acetyl-muramyl-L-alanyl-D-glutamic-alpha-amide(MDP) or -alpha-methyl ester derivatives, bearing a lipophilic group at the C-terminal peptide end.
    Lefrancier P; Petitou M; Level M; Derrien M; Choay J; Lederer E
    Int J Pept Protein Res; 1979; 14(5):437-44. PubMed ID: 536111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epithelioid granuloma formation by a synthetic bacterial cell wall component, muramyl dipeptide (MDP).
    Tanaka A; Emori K
    Am J Pathol; 1980 Mar; 98(3):733-48. PubMed ID: 6767407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.